CAMBRIDGE, Mass., Feb. 7 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. today announced that its presentation at the BIO CEO & Investor 2007 Conference will be webcast live and may be accessed by visiting the Investors section of the Company’s website, www.millennium.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO)
Millennium management will provide an overview of the Company and upcoming corporate events. The presentation will be delivered at 1:30 p.m. ET on Wednesday, February 14, 2007 from the Waldorf Astoria Hotel in New York, NY. The presentation will be archived for 30 days.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company’s research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company’s website is www.millennium.com.
Editors’ Note: This press release is also available under the Media section of the Company’s website at: www.millennium.com.
Contact:
Kyle Kuvalanka
(617) 761-4734
Photo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGOAP Archive: http:Millennium Pharmaceuticals, Inc.
CONTACT: Kyle Kuvalanka of Millennium Pharmaceuticals, Inc.,+1-617-761-4734
Web site: http://www.millennium.com//
Company News On-Call: http://www.prnewswire.com/comp/114562.html/
